Label-Free Nanosensing Platform for Breast Cancer Exosome Profiling

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Diagnostics

Background:

• Breast cancer diagnosis often relies on invasive methods, limiting early detection and treatment success.
• Exosomes in circulation offer a promising non-invasive source for cancer biomarkers.
• Current exosome analysis techniques are complex, time-consuming, and expensive.

Purpose of the Study:

• To develop a cost-effective and green surface-enhanced Raman spectroscopy (SERS) substrate for exosome analysis.
• To enable early, non-invasive breast cancer diagnosis using Raman spectroscopy of exosomes.

Main Methods:

• Composites of bacterial nanocellulose (from nata de coco) and in-situ-synthesized silver nanoparticles were fabricated as SERS substrates.
• Raman spectroscopy was employed for analyzing exosomes from breast cancer (MDA-MB-231) and non-tumorigenic (MCF-10A) cell lines.
• Principal Component Analysis (PCA) was utilized to analyze spectral data for distinguishing between cell types.

Main Results:

• The synthesized SERS substrates achieved enhancement factors of 10^4 to 10^5, detecting Rhodamine 6G at concentrations as low as 10^-11 M.
• Raman spectra of exosomes from different cell lines were successfully differentiated using PCA.
• Accurate data grouping with 95% confidence was achieved, demonstrating the method's specificity.

Conclusions:

• The developed bacterial nanocellulose-silver nanoparticle composite is a promising, low-cost, and green SERS substrate for exosome analysis.
• This label-free approach shows significant potential for early, non-invasive breast cancer diagnosis in clinical settings.